Cardiovascular inhibitory effects of Hyoscyamus niger

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 30, Issue 4, 2008, Pages 295-300

  Khan, A U ^a,b   Gilani, Anwarul Hassan ^a  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Calcium antagonist; Cardiodepressant; Hyoscyamus niger; Hypotensive; Vasodilator

Indexed keywords

ALKALOID; ANTHRAQUINONE DERIVATIVE; CALCIUM ION; COUMARIN DERIVATIVE; FLAVONOID; HYOSCYAMUS NIGER EXTRACT; N(G) NITROARGININE METHYL ESTER; PHENYLEPHRINE; PHYTOSTEROL; PLANT EXTRACT; POTASSIUM ION; SAPONIN; TANNIN DERIVATIVE; TERPENE; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CALCIUM TRANSPORT; CARDIOVASCULAR RESPONSE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG MECHANISM; DRUG SCREENING; FEMALE; GUINEA PIG; HEART ATRIUM CONTRACTION; HYOSCYAMUS; MALE; NONHUMAN; PHYTOCHEMISTRY; RABBIT;

ANIMALS; AORTA; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; GUINEA PIGS; HEART ATRIA; HYOSCYAMUS; MALE; MYOCARDIAL CONTRACTION; PLANT EXTRACTS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS; VERAPAMIL;

EID: 52649131241     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2008.30.4.1186075     Document Type: Article

References (42)

1. Nadkarni, K.M. Indian Materia. Medica (3rd ed.). Popular Prakashan: Bombay 1976, 670-72.
2. Usmanghani, K., Saeed, A., Alam, M.T. Indusyunic Medicine. University of Karachi Press: Karachi 1997, 258-9.
3. Duke, J.A., Bogenschutz-Godwin, M.J., Du celliar, J. et al. Hand Book of Medicinal Herbs (2nd ed.). CRC Press: Boca Raton 2002, 373-4.
4. Wang, S., Huang, F., Fu, Y. et al. The effect of hyoscyamine drugs on the fluidity of phospholipids model membrane by a differential scanning calorimetric method. Kexue Tong Ban 1983, 28(5): 693-6.
5. Jaziri, M., Legros, M., Homes, J. et al. Tropane alkaloids production by hairy root cultures of Datura stramonium and Hyoscyamus niger. Phytochemistry 1988, 27(2): 419-20.
6. Duke, J.A. Handbook of Phytochemical Constituents of GRAS Herbs and Other Economical Plants. CRC Press: London 1992, 302-3.
7. Ma, C.Y., Liu, W.K., Che, C.T. Lignanamides and non-alkaloid components of Hyoscyamus niger seeds. J Nat Prod 2002, 65(2): 206-9.
8. Drager, B., Almsick, A.V., Mrachatz, G. Distribution of caly-stegines in several solanaceae plants. Planta Med 2002, 61(6): 567-8.
9. Ma, C.Y., Williams, I.D., Che, C.T. Withanolides from Hyoscyamus niger seeds. J Nat Prod 1999, 62(10): 1445-7.
10. Chinese Pharmacopoeia (Vol. 1). Chemical Industry Press: Beijing 2000, 41.
11. Wilhelm, H., Wilhelm, B., Schiefer, U. Mydriasis caused by plant contact. Fortsch Der Ophthalmol 1991, 88(5): 588-91.
12. Della-Loggia, R., Tubaro, A., Redaelli, C. Evaluation of the activity on the mice CNS of several plant extracts and a combination of them. Rivista di Neurol 1981, 51(5): 297-310.
13. ++ channels. Fund Clin Pharm 2008, 22: 87-99.
14. Williamson, E.M., Okpako, D.T., Evans, F.J. Selection, Preparation and Pharmacological Evaluation of Plant Material. Wiley: Chichester 1998, 15-23.
15. National Research Council. Guide for the Care and Use of Laboratory Animals. National Academy Press: Washington 1996, 1-7.
16. Edeoga, H.O., Okwu, D.E., Mbaebie, B.O. Phytochemical constituents of some Nigerian medicinal plants. Afr J Biotechnol 2005, 4(7): 685-8.
17. Evans, W.C. Trease and Evan's Pharmacognosy (14th ed.). WB Sounders: London 1996, 161-408.
18. Harbome, J.B. Phytochemical Methods (2nd ed.). Chapman & Hall: New York 1984, 73-89.
19. Gilani, A.H., Khan, A., Shah, A.J. et al. Blood pressure lowering effect of olives is mediated through calcium channel blockade. Int J Food Sci Nutr 2005, 56(8): 613-20.
20. Tanaka, M., Masumiya, H., Sekine, S. et al. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem. Gen Pharmacol 1996, 27(3): 451-4.
21. Gilani, A.H., Ghayur, M.N., Houghton, P.J. et al. Studies on the hypotensive, cardio-suppressant, vasodilator and antiplatelet activities of betel nut crude extract and its constituents. Int J Pharmacol 2006, 2(1): 33-41.
22. Karaki, H., Ozaki, H., Hori, M. et al. Calcium movements, distribution and functions in smooth muscle. Pharmacol Rev 1997, 49(2): 157-230.
23. Wang, G.J., Shum, A.Y., Lin, Y.L. et al. Calcium channel blockade in vascular smooth muscle cells: Major hypotensive mechanism of S-petasin, a hypotensive sesquiterpene from Petasites formosanus. J Pharmacol Exp Ther 2001, 297(1): 240-46.
24. Guan, Y.Y., Kwan, C.Y., Daniel, E.E. The effects of EGTA on vascular smooth muscle contractility in calcium free medium. Can J Physiol Pharmacol 1988, 66(8): 1053-6.
25. Hashimoto, M., Hirata, M., Itoh, T. et al. Inositol 1,4,5-triphosphate activates pharmaco-mechanical coupling in smooth muscle of rabbit mesenteric artery. J Physiol 1986, 370(1): 605-18.
26. Cauvin, C., Malik, S. Induction of calcium influx and calcium release in isolated rat aorta and mesenteric resistance vessels by norepinephrine activation of alpha-receptors. J Pharmacol Exp Ther 1984, 230(2): 413-8.
27. Furchgott, R.F., Zawadski, J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288(5789): 373-6.
28. Johansen, P.L. Hemodynamic effects of calcium antagonists in hypertension. In: Calcium Antagonists in Clinical Medicine. Epstein, M. (Ed.). Hanley and Belfus: Philadelphia 1992, 69-88.
29. Okmura, K., Ichihara, K., Nagaska, M. et al. Calcium entry blocking activities of MPC-1304 and of its enantiomers and metabolites. Eur J Pharmacol 1993, 235(1): 69-74.
30. Chan, S.S., Choi, A.O., Jones, R.L. et al. Mechanisms underlying the vasorelaxing effects of butylidenephthalide, an active constituent of Ligusticum chuanxiong in rat isolated aorta. Eur J Pharmacol 2006, 537 (1-3): 111-7.
31. + induced contractions of smooth muscles in rat aorta and guinea-pig tenia cecum. Biol Pharm Bull 2005, 28(8): 1521-3.
32. Bolton, T.B. Mechanism of action of transmitters and other substances on smooth muscles. Physiol Rev 1979, 59(3): 606-718.
33. Hall, J., Jones, T.H., Channer, K.S. et al. Mechanisms of agonist-induced constriction in isolated human mesenteric arteries. Vasc Pharmacol 2006, 44(6): 427-33.
34. ++ from intracellular stores of the rat portal vein stimulates a tonic contraction. Ent J Pharmacol 2005, 510(1-2): 97-105.
35. Ghayur, M.N., Gilani, A.H. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J Cardiovasc Pharmacol 2005, 45(1): 74-80.
36. ++ in myocardium, cardiac pacemakers and vascular smooth muscle. Ann Rev Pharmacol Toxicol 1977, 17: 149-66.
37. ++ antagonists. Gen Pharmacol 1991, 22(1): 177-81.
38. 2-adrenoceptor-mediated endothelium-dependent vasodilation. Circ Res 1998, 82(12): 1323-9.
39. ++, phosphorylation of myosin regulatory light chain and force in rat smooth muscle. J Physiol 1997, 499(2): 485-96.
40. Ajay, M., Gilani, A.H., Mustafa, M.R. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci 2003, 74(5): 603-12.
41. Knekt, P., Jarvinen, R., Reunanen, A. et al. Flavonoid intake and coronary mortality in Finland: A comparative study. Br Med J 1996, 312(7029): 478-81.
42. Pietta, P. Flavonoids in medicinal plants. In: Flavonoids in Health and Disease. Rive-Evans, C.V., Packer, L. (Eds.). Marcel Dekker: New York 1998, 61-110.